|
Market Closed -
Nasdaq
08:00:00 14/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.4130 USD | -6.16% |
|
-5.36% | -73.86% |
| 12/10 | Certain Common Stock of Outlook Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 12-OCT-2026. | CI |
| 10/10 | Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OTLK | Delayed | |
| OTLK | Real-time | ||
| 41O | Real-time | ||
| 41O | Delayed | ||
| 41O | Delayed | ||
| 41O | Real-time | ||
| 41O | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 0.5133 | 1.83 | 2.05 |
| Spread/Res. | -19.54% | -77.43% | -79.85% |
| Spread/Supp. | -5.36% | +81.06% | +98.46% |
| Support | 0.4364 | 0.2281 | 0.2081 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- OTLK Stock
- Charts Outlook Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















